Immunosuppressant External Quality Assessment

The RIQAS Immunosuppressant EQA programme has been designed to cover the analysis of Immunosuppressants in clinical laboratories. Immunosuppressants are primarily used after transplant operations to prevent the host body from rejecting donor organs.

  • Lyophilised samples
  • Monthly reporting
  • Testing covers the full range of clinically relevant decision levels
  • Submit results and view reports online via RIQAS.net
  • 12 month subscription
  • LC/MS reference values provided enabling participants to compare results to an accurately assigned value

Not accredited to ISO/IEC 17043

[table id=409 datatables_row_details=true datatables_row_details_columns=”F” /]

Parameters

  • Cyclosporin
  • Everolimus
  • Sirolimus
  • Tacrolimus
Clinical Laboratory Survey